The effects of green tea polyphenols on drug metabolism

Bibliography

• Yang CS, Wang X, Lu G, Picinich SC. Cancer prevention by tea: animal studies, molecular mechanisms and human relevance. Nat Rev Cancer 2009;9(6):429-39
   PubMed Web of Science ®Google Scholar
• Yang CS, Lambert JD. Research on tea and health. Pharmacol Res 2011;64(2):85-6
   PubMed Web of Science ®Google Scholar
• Deka A, Vita JA. Tea and cardiovascular disease. Pharmacol Res 2011;64(2):136-45
   PubMed Web of Science ®Google Scholar
• Lambert JD, Sang S, Yang CS. Possible controversy over dietary polyphenols: benefits vs risks. Chem Res Toxicol 2007;20(4):583-5
   PubMed Web of Science ®Google Scholar
• Schonthal AH. Adverse effects of concentrated green tea extracts. Mol Nutr Food Res 2011;55(6):874-85
   PubMedGoogle Scholar
• Sang S, Lambert JD, Ho CT, Yang CS. The chemistry and biotransformation of tea constituents. Pharmacol Res 2011;64(2):87-99
   PubMed Web of Science ®Google Scholar
• Products List. Dietary Supplements Labels Database. Available from: http://dietarysupplements.nlm.nih.gov/dietary/brand.jsp [Cited January 2012]
   Google Scholar
• Hou Z, Sang S, You H, Mechanism of action of (-)-epigallocatechin-3-gallate: auto-oxidation-dependent inactivation of epidermal growth factor receptor and direct effects on growth inhibition in human esophageal cancer KYSE 150 cells. Cancer Res 2005;65(17):8049-56
   PubMed Web of Science ®Google Scholar
• Lu H, Meng X, Yang CS. Enzymology of methylation of tea catechins and inhibition of catechol-O-methyltransferase by (-)-epigallocatechin gallate. Drug Metab Dispos 2003;31(5):572-9
   PubMed Web of Science ®Google Scholar
• Lu H, Meng X, Li C, Glucuronides of tea catechins: enzymology of biosynthesis and biological activities. Drug Metab Dispos 2003;31(4):452-61
   PubMed Web of Science ®Google Scholar
• Lu H. Mechanistic studies on the Phase II metabolism and absorption of tea catechins. Toxicology. The State University of New Jersey; Rutgers, New Brunswick: 2002
   Google Scholar
• Vaidyanathan JB, Walle T. Glucuronidation and sulfation of the tea flavonoid (-)-epicatechin by the human and rat enzymes. Drug Metab Dispos 2002;30(8):897-903
   PubMed Web of Science ®Google Scholar
• Sang S, Lee MJ, Yang I, Human urinary metabolite profile of tea polyphenols analyzed by liquid chromatography/electrospray ionization tandem mass spectrometry with data-dependent acquisition. Rapid Commun Mass Spectrom 2008;22(10):1567-78
   PubMedGoogle Scholar
• Sang S, Lambert JD, Hong J, Synthesis and structure identification of thiol conjugates of (-)-epigallocatechin gallate and their urinary levels in mice. Chem Res Toxicol 2005;18(11):1762-9
   PubMed Web of Science ®Google Scholar
• Leslie EM, Deeley RG, Cole SP. Toxicological relevance of the multidrug resistance protein 1, MRP1 (ABCC1) and related transporters. Toxicology 2001;167(1):3-23
   PubMed Web of Science ®Google Scholar
• Hong J, Lambert JD, Lee SH, Involvement of multidrug resistance-associated proteins in regulating cellular levels of (-)-epigallocatechin-3-gallate and its methyl metabolites. Biochem Biophys Res Commun 2003;310(1):222-7
   PubMed Web of Science ®Google Scholar
• Hong J, Lu H, Meng X, Stability, cellular uptake, biotransformation, and efflux of tea polyphenol (-)-epigallocatechin-3-gallate in HT-29 human colon adenocarcinoma cells. Cancer Res 2002;62(24):7241-6
   PubMed Web of Science ®Google Scholar
• Lambert JD, Sang S, Lu AY, Yang CS. Metabolism of dietary polyphenols and possible interactions with drugs. Curr Drug Metab 2007;8(5):499-507
   PubMed Web of Science ®Google Scholar
• Taipalensuu J, Tornblom H, Lindberg G, Correlation of gene expression of ten drug efflux proteins of the ATP-binding cassette transporter family in normal human jejunum and in human intestinal epithelial Caco-2 cell monolayers. J Pharmacol Exp Ther 2001;299(1):164-70
   PubMed Web of Science ®Google Scholar
• Chen L, Lee MJ, Li H, Yang CS. Absorption, distribution, elimination of tea polyphenols in rats. Drug Metab Dispos 1997;25(9):1045-50
   PubMed Web of Science ®Google Scholar
• Lambert JD, Lee MJ, Lu H, Epigallocatechin-3-gallate is absorbed but extensively glucuronidated following oral administration to mice. J Nutr 2003;133(12):4172-7
   PubMed Web of Science ®Google Scholar
• Yang CS, Chen L, Lee MJ, Blood and urine levels of tea catechins after ingestion of different amounts of green tea by human volunteers. Cancer Epidemiol Biomarkers Prev 1998;7(4):351-4
   PubMed Web of Science ®Google Scholar
• Chow HH, Cai Y, Alberts DS, Phase I pharmacokinetic study of tea polyphenols following single-dose administration of epigallocatechin gallate and polyphenon E. Cancer Epidemiol Biomarkers Prev 2001;10(1):53-8
   PubMed Web of Science ®Google Scholar
• Lee MJ, Maliakal P, Chen L, Pharmacokinetics of tea catechins after ingestion of green tea and (-)-epigallocatechin-3-gallate by humans: formation of different metabolites and individual variability. Cancer Epidemiol Biomarkers Prev 2002;11(10 Pt 1):1025-32
   PubMed Web of Science ®Google Scholar
• Chow HH, Cai Y, Hakim IA, Pharmacokinetics and safety of green tea polyphenols after multiple-dose administration of epigallocatechin gallate and polyphenon E in healthy individuals. Clin Cancer Res 2003;9(9):3312-19
   PubMed Web of Science ®Google Scholar
• Chow HH, Hakim IA, Vining DR, Effects of dosing condition on the oral bioavailability of green tea catechins after single-dose administration of Polyphenon E in healthy individuals. Clin Cancer Res 2005;11(12):4627-33
   PubMed Web of Science ®Google Scholar
• Mulder TP, van Platerink CJ, Wijnand Schuyl PJ, van Amelsvoort JM. Analysis of theaflavins in biological fluids using liquid chromatography-electrospray mass spectrometry. J Chromatogr B Biomed Sci Appl 2001;760:271-9
   PubMed Web of Science ®Google Scholar
• Choi YH, Chin YW, Kim YG. Herb-drug interactions: focus on metabolic enzymes and transporters. Arch Pharm Res 2011;34(11):1843;63
   Google Scholar
• Ge J, Tan BX, Chen Y, Interaction of green tea polyphenol epigallocatechin-3-gallate with sunitinib: potential risk of diminished sunitinib bioavailability. J Mol Med (Berl) 2011;89(6):595-602
   PubMed Web of Science ®Google Scholar
• Golden EB, Lam PY, Kardosh A, Green tea polyphenols block the anticancer effects of bortezomib and other boronic acid-based proteasome inhibitors. Blood 2009;113(23):5927-37
   PubMed Web of Science ®Google Scholar
• Kim M, Hong J. Analysis of Chemical Interactions of (-)-Epigallocatechin-3-gallate, a major green tea polyphenol, with commonly-consumed over-the-counter drugs. Food Sci Biotechnol 2010;19:559-64
   Google Scholar
• Chen D, Wang CY, Lambert JD, Inhibition of human liver catechol-O-methyltransferase by tea catechins and their metabolites: structure-activity relationship and molecular-modeling studies. Biochem Pharmacol 2005;69(10):1523-31
   Web of Science ®Google Scholar
• Muto S, Fujita K, Yamazaki Y, Kamataki T. Inhibition by green tea catechins of metabolic activation of procarcinogens by human cytochrome P450. Mutat Res 2001;479(1-2):197-206
   PubMed Web of Science ®Google Scholar
• Netsch MI, Gutmann H, Schmidlin CB, Induction of CYP1A by green tea extract in human intestinal cell lines. Planta Med 2006;72(6):514-20
   PubMedGoogle Scholar
• Wanwimolruk S, Wong K, Wanwimolruk P. Variable inhibitory effect of different brands of commercial herbal supplements on human cytochrome P-450 CYP3A4. Drug Metabol Drug Interact 2009;24(1):17-35
   PubMedGoogle Scholar
• Kamenickova A, Vrzal R, Dvorak Z. Effects of ready to drink teas on AhR- and PXR-mediated expression of cytochromes P450 CYP1A1 and CYP3A4 in human cancer cell lines and primary human hepatocytes. Food Chem 2011;131:1201-6
   Google Scholar
• Yang SP, Raner GM. Cytochrome P450 expression and activities in human tongue cells and their modulation by green tea extract. Toxicol Appl Pharmacol 2005;202(2):140-50
   PubMedGoogle Scholar
• Fong YK, Li CR, Wo SK, In vitro and in situ evaluation of herb-drug interactions during intestinal metabolism and absorption of Baicalein. J Ethnopharmacol 2011
   Google Scholar
• Mohamed ME, Frye RF. Inhibitory effects of commonly used herbal extracts on UDP-glucuronosyltransferase 1A4, 1A6, and 1A9 enzyme activities. Drug Metab Dispos 2011;39(9):1522-8
   PubMedGoogle Scholar
• Mohamed MF, Tseng T, Frye RF. Inhibitory effects of commonly used herbal extracts on UGT1A1 enzyme activity. Xenobiotica 2010;40(10):663-9
   PubMed Web of Science ®Google Scholar
• Shimada T. Xenobiotic-metabolizing enzymes involved in activation and detoxification of carcinogenic polycyclic aromatic hydrocarbons. Drug Metab Pharmacokinet 2006;21(4):257-76
   PubMed Web of Science ®Google Scholar
• Pool-Zobel B, Veeriah S, Bohmer FD. Modulation of xenobiotic metabolising enzymes by anticarcinogens – focus on glutathione S-transferases and their role as targets of dietary chemoprevention in colorectal carcinogenesis. Mutat Res 2005;591(1-2):74-92
   PubMedGoogle Scholar
• Chen C, Yu R, Owuor ED, Kong AN. Activation of antioxidant-response element (ARE), mitogen-activated protein kinases (MAPKs) and caspases by major green tea polyphenol components during cell survival and death. Arch Pharm Res 2000;23(6):605-12
   PubMed Web of Science ®Google Scholar
• Tan XL, Shi M, Tang H, Candidate dietary phytochemicals modulate expression of phase II enzymes GSTP1 and NQO1 in human lung cells. J Nutr 2010;140(8):1404-10
   PubMedGoogle Scholar
• Farabegoli F, Papi A, Bartolini G, (-)-Epigallocatechin-3-gallate downregulates Pg-P and BCRP in a tamoxifen resistant MCF-7 cell line. Phytomedicine 2010;17(5):356-62
   PubMed Web of Science ®Google Scholar
• Jodoin J, Demeule M, Beliveau R. Inhibition of the multidrug resistance P-glycoprotein activity by green tea polyphenols. Biochim Biophys Acta 2002;1542(1-3):149-59
   PubMed Web of Science ®Google Scholar
• Qian F, Wei D, Zhang Q, Yang S. Modulation of P-glycoprotein function and reversal of multidrug resistance by (-)-epigallocatechin gallate in human cancer cells. Biomed Pharmacother 2005;59(3):64-9
   PubMed Web of Science ®Google Scholar
• Zhu A, Wang X, Guo Z. Study of tea polyphenol as a reversal agent for carcinoma cell lines' multidrug resistance (study of TP as a MDR reversal agent). Nucl Med Biol 2001;28(6):735-40
   PubMed Web of Science ®Google Scholar
• Kitagawa S, Nabekura T, Kamiyama S. Inhibition of P-glycoprotein function by tea catechins in KB-C2 cells. J Pharm Pharmacol 2004;56(8):1001-5
   PubMed Web of Science ®Google Scholar
• Mei Y, Qian F, Wei D, Liu J. Reversal of cancer multidrug resistance by green tea polyphenols. J Pharm Pharmacol 2004;56(10):1307-14
   PubMedGoogle Scholar
• Netsch MI, Gutmann H, Luescher S, Inhibitory activity of a green tea extract and some of its constituents on multidrug resistance-associated protein 2 functionality. Planta Med 2005;71(2):135-41
   PubMed Web of Science ®Google Scholar
• Jang EH, Choi JY, Park CS, Effects of green tea extract administration on the pharmacokinetics of clozapine in rats. J Pharm Pharmacol 2005;57(3):311-16
   PubMedGoogle Scholar
• Niwattisaiwong N, Luo XX, Coville PF, Wanwimolruk S. Effects of Chinese, Japanese and Western tea on hepatic P450 enzyme activities in rats. Drug Metabol Drug Interact 2004;20(1-2):43-56
   PubMedGoogle Scholar
• Park D, Jeon JH, Shin S, Green tea extract increases cyclophosphamide-induced teratogenesis by modulating the expression of cytochrome P-450 mRNA. Reprod Toxicol 2009;27(1):79-84
   PubMedGoogle Scholar
• Chen X, Sun CK, Han GZ, Protective effect of tea polyphenols against paracetamol-induced hepatotoxicity in mice is significantly correlated with cytochrome P450 suppression. World J Gastroenterol 2009;15(15):1829-35
   PubMed Web of Science ®Google Scholar
• Srinivasan P, Suchalatha S, Babu PV, Chemopreventive and therapeutic modulation of green tea polyphenols on drug metabolizing enzymes in 4-Nitroquinoline 1-oxide induced oral cancer. Chem Biol Interact 2008;172(3):224-34
   PubMedGoogle Scholar
• Sahin K, Tuzcu M, Gencoglu H, Epigallocatechin-3-gallate activates Nrf2/HO-1 signaling pathway in cisplatin-induced nephrotoxicity in rats. Life Sci 2010;87(7-8):240-5
   PubMed Web of Science ®Google Scholar
• Tulayakul P, Dong KS, Li JY, The effect of feeding piglets with the diet containing green tea extracts or coumarin on in vitro metabolism of aflatoxin B1 by their tissues. Toxicon 2007;50(3):339-48
   PubMedGoogle Scholar
• Liu TT, Liang NS, Li Y, Effects of long-term tea polyphenols consumption on hepatic microsomal drug-metabolizing enzymes and liver function in Wistar rats. World J Gastroenterol 2003;9(12):2742-4
   PubMedGoogle Scholar
• Maliakal PP, Coville PF, Wanwimolruk S. Tea consumption modulates hepatic drug metabolizing enzymes in Wistar rats. J Pharm Pharmacol 2001;53(4):569-77
   PubMedGoogle Scholar
• Shen G, Xu C, Hu R, Comparison of (-)-epigallocatechin-3-gallate elicited liver and small intestine gene expression profiles between C57BL/6J mice and C57BL/6J/Nrf2 (-/-) mice. Pharm Res 2005;22(11):1805-20
   PubMedGoogle Scholar
• Catterall F, McArdle NJ, Mitchell L, Hepatic and intestinal cytochrome P450 and conjugase activities in rats treated with black tea theafulvins and theaflavins. Food Chem Toxicol 2003;41(8):1141-7
   PubMedGoogle Scholar
• Borst P, Evers R, Kool M, Wijnholds J. A family of drug transporters: the multidrug resistance-associated proteins. J Natl Cancer Inst 2000;92(16):1295-302
   PubMed Web of Science ®Google Scholar
• Barrand MA, Bagrij T, Neo SY. Multidrug resistance-associated protein: a protein distinct from P-glycoprotein involved in cytotoxic drug expulsion. Gen Pharmacol 1997;28(5):639-45
   PubMedGoogle Scholar
• Kitagawa S, Nabekura T, Takahashi T, Structure-activity relationships of the inhibitory effects of flavonoids on P-glycoprotein-mediated transport in KB-C2 cells. Biol Pharm Bull 2005;28(12):2274-8
   PubMedGoogle Scholar
• Nishikawa M, Ariyoshi N, Kotani A, Effects of continuous ingestion of green tea or grape seed extracts on the pharmacokinetics of midazolam. Drug Metab Pharmacokinet 2004;19(4):280-9
   PubMedGoogle Scholar
• Shin SC, Choi JS. Effects of epigallocatechin gallate on the oral bioavailability and pharmacokinetics of tamoxifen and its main metabolite, 4-hydroxytamoxifen, in rats. Anticancer Drugs 2009;20(7):584-8
   PubMed Web of Science ®Google Scholar
• Choi JS, Burm JP. Effects of oral epigallocatechin gallate on the pharmacokinetics of nicardipine in rats. Arch Pharm Res 2009;32(12):1721-5
   PubMedGoogle Scholar
• Li C, Choi JS. Effects of epigallocatechin gallate on the bioavailability and pharmacokinetics of diltiazem in rats. Pharmazie 2008;63(11):815-18
   PubMed Web of Science ®Google Scholar
• Chung JH, Choi DH, Choi JS. Effects of oral epigallocatechin gallate on the oral pharmacokinetics of verapamil in rats. Biopharm Drug Dispos 2009;30(2):90-3
   PubMed Web of Science ®Google Scholar
• Liang G, Tang A, Lin X, Green tea catechins augment the antitumor activity of doxorubicin in an in vivo mouse model for chemoresistant liver cancer. Int J Oncol 2010;37(1):111-23
   PubMed Web of Science ®Google Scholar
• Lin LC, Wang MN, Tsai TH. Food-drug interaction of (-)-epigallocatechin-3-gallate on the pharmacokinetics of irinotecan and the metabolite SN-38. Chem Biol Interact 2008;174(3):177-82
   PubMed Web of Science ®Google Scholar
• Chow HH, Hakim IA, Vining DR, Effects of repeated green tea catechin administration on human cytochrome P450 activity. Cancer Epidemiol Biomarkers Prev 2006;15(12):2473-6
   PubMed Web of Science ®Google Scholar
• Donovan JL, Chavin KD, Devane CL, Green tea (Camellia sinensis) extract does not alter cytochrome p450 3A4 or 2D6 activity in healthy volunteers. Drug Metab Dispos 2004;32(9):906-8
   PubMed Web of Science ®Google Scholar
• Chow HH, Hakim IA, Vining DR, Modulation of human glutathione s-transferases by polyphenon e intervention. Cancer Epidemiol Biomarkers Prev 2007;16(8):1662-6
   PubMed Web of Science ®Google Scholar
• Williams SN, Pickwell GV, Quattrochi LC. A combination of tea (Camellia senensis) catechins is required for optimal inhibition of induced CYP1A expression by green tea extract. J Agric Food Chem 2003;51(22):6627-34
   PubMed Web of Science ®Google Scholar
• Engdal S, Nilsen OG. In vitro inhibition of CYP3A4 by herbal remedies frequently used by cancer patients. Phytother Res 2009;23(7):906-12
   PubMed Web of Science ®Google Scholar
• Mirkov S, Komoroski BJ, Ramirez J, Effects of green tea compounds on irinotecan metabolism. Drug Metab Dispos 2007;35(2):228-33
   PubMed Web of Science ®Google Scholar
• Isozaki T, Tamura H. Epigallocatechin gallate (EGCG) inhibits the sulfation of 1-naphthol in a human colon carcinoma cell line, Caco-2. Biol Pharm Bull 2001;24(9):1076-8
   PubMed Web of Science ®Google Scholar
• Revesz K, Tutto A, Margittai E, Glucuronide transport across the endoplasmic reticulum membrane is inhibited by epigallocatechin gallate and other green tea polyphenols. Int J Biochem Cell Biol 2007;39(5):922-30
   PubMed Web of Science ®Google Scholar
• Marnewick JL, Joubert E, Swart P, Modulation of hepatic drug metabolizing enzymes and oxidative status by rooibos (Aspalathus linearis) and Honeybush (Cyclopia intermedia), green and black (Camellia sinensis) teas in rats. J Agric Food Chem 2003;51(27):8113-19
   PubMed Web of Science ®Google Scholar
• Takizawa Y, Kitazato T, Kishimoto H, Effects of antioxidants on drug absorption in in vivo intestinal ischemia/reperfusion. Eur J Drug Metab Pharmacokinet 2011;35(3-4):89-95
   PubMed Web of Science ®Google Scholar
• Qiao J, Gu C, Shang W, Effect of green tea on pharmacokinetics of 5-fluorouracil in rats and pharmacodynamics in human cell lines in vitro. Food Chem Toxicol 2011;49(6):1410-15
   PubMed Web of Science ®Google Scholar